We reiterate our BUY and SEK240 target price, having fine-tuned our forecast after the soft Q1 revenue due to few new releases. Looking ahead, we expect revenue and earnings growth to improve from new releases, and coupled with a more stable capex profile, we see healthy FCF growth for 2025e. Additionally, we believe Paradox is well positioned for rising shareholder distributions and more bolt-on M&A.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.